Mental Health News and Research

Latest Mental Health News and Research

Euthymics's EB-1010 effective in treatment of major depressive disorder: Study

Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.

9 Dec 2010

Cipher Phase 3 dermatology study uses MedAvante Centralized Ratings

MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study.

8 Dec 2010

Integrating smoking cessation treatment with mental health care improves abstinence rates in PTSD veterans

Among smokers with military-related posttraumatic stress disorder (PTSD), integrating smoking cessation treatment with mental health care for PTSD resulted in higher rates of prolonged smoking abstinence, compared to referral for assistance with quitting smoking, according to a study in the December 8 issue of JAMA.

8 Dec 2010

Sleep deprivation eliminates fear-associated memories

We commonly think of sleep as a healing process that melts away the stresses of the day, preparing us to deal with new challenges. Research has also shown that sleep plays a crucial role in the development of memories.

8 Dec 2010

Omega-3 fatty acids have antidepressant properties: Study

A new analysis of the effects of omega-3 essential fatty acids offers the hope of enhanced treatment options for tens of millions of people with depression. Two critical omega-3 essential fatty acids available from certain food or nutritional supplements but not manufactured by the body—Eicosapentenoic acid (EPA) and docosahexaenoic (DHA) — play a role in optimal brain functioning and have antidepressant benefits that have not been fully recognized.

8 Dec 2010

Loss of healthy bacteria may contribute to increasing rates of depression, say researchers

In an effort to pinpoint potential triggers leading to inflammatory responses that eventually contribute to depression, researchers are taking a close look at the immune system of people living in today's cleaner modern society.

8 Dec 2010

Research to improve prognosis for patients with dementia and Alzheimer's disease

Research on preventing the devastating onset of dementia is about to break new ground as McGill University, in partnership with Pfizer Canada, has announced today the creation of a professorship for the prevention of dementia and Alzheimer's-related diseases.

8 Dec 2010

FDA advisory committee's approval of Contrave for obesity encourages OAC, TOS, ASMBS

The Obesity Action Coalition, The Obesity Society and the American Society for Metabolic and Bariatric Surgery found encouragement in the outcome of today's advisory committee hearing, favoring approval for the first new obesity treatment in more than 10 years.

8 Dec 2010

Jackson Health System selects MedAssets as its strategic partner

MedAssets, Inc. announced today that Jackson Health System has selected the Company as its strategic partner to implement MedAssets' transformational approach to significantly lower supply costs, drive operational efficiencies and engage physicians in the cost and clinical utilization management improvement process.

8 Dec 2010

Alexza Pharmaceuticals to meet with FDA to discuss CRL regarding its NDA for AZ-004

Alexza Pharmaceuticals, Inc. announced today that the Company has scheduled an End-of Review meeting with the U.S. Food and Drug Administration in December to discuss the Complete Response Letter regarding the Company's New Drug Application for AZ-004 (Staccato loxapine).

8 Dec 2010

Psychotic depression: the reason for treatment failure with antidepressants

A new study shows that patients with depression who also have psychotic-like symptoms, feelings of being persecuted, or believing others are plotting against them or hearing voices are less likely to respond to antidepressants. The study also showed that bipolar disorder does not appear to be associated with treatment resistance in patients with depression as believed earlier.

7 Dec 2010

Mental Health Research Network receives grant to create data resource for mental health researchers

Ask anyone: There must be better ways to treat mental health problems. Treatment hinges on research. But traditional research is slow-and so expensive that it can't even ask many pressing questions in mental health. And findings from academic settings may not apply to patients or clinicians in the real world of health care.

7 Dec 2010

Clinicians should specify subtypes of depression and combine antidepressants and psychotherapy

It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.

7 Dec 2010

Expansion of newborn screening throws some families on a journey of great uncertainty

Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.

7 Dec 2010

Major depression reduces success rate of quitting smoking

Depressed smokers want to quit the nicotine habit just as much as non-depressed smokers, but a new study suggests that depression can put a kink in their success.

7 Dec 2010

People suffering psychotic disorders 12 times more likely to commit suicide

People with psychotic disorders, such as schizophrenia or bipolar disorder, are 12 times more likely to commit suicide than average, according to research released today by King's Health Partners.

7 Dec 2010

Drug prescribed for Parkinson's disease may also treat restless leg syndrome: MCG researchers

A drug prescribed for Parkinson's disease may also treat restless leg syndrome without the adverse side effects of current therapies, Medical College of Georgia researchers say.

7 Dec 2010

Researchers develop new drugs to prevent post-traumatic stress syndrome

Post-traumatic stress syndrome - when a severely stressful event triggers exaggerated and chronic fear - affects nearly 8 million people in the United States and is hard to treat. In a preclinical study, Northwestern Medicine scientists have for the first time identified the molecular cause of the debilitating condition and prevented it from occurring by injecting calming drugs into the brain within five hours of a traumatic event.

7 Dec 2010

State roundup: Wash. state to pay most of state worker premiums; Budget cuts and mental health in N.Y.; Idaho fraud

Gov. Chris Gregoire told state workers for months that they'd have to pay a bigger share of health-care costs — equal to 26 percent of their health-insurance premiums — because of a looming multibillion-dollar budget shortfall. That all changed when Gregoire's office agreed this week to have workers pay 15 percent of health-care premium costs, with the state picking up the other 85 percent in the next two-year budget (Garber, 12/3).

7 Dec 2010

Frisky old men - still keen and active: Sex study

According to the latest Australian study, men at 75 and older have not said good bye to their sex lives yet. They found that nearly one third of these older men were sexually active at least once a year -- including about 1 in 10 men aged 90 to 95. Many of these men have agreed that they would want more of sex and those not sexually active are blaming health issues, low testosterone or lack of partners. The findings appear in the Dec. 7 issue of the Annals of Internal Medicine.

6 Dec 2010

Mental Health News and Research

Latest Mental Health News and Research

Euthymics's EB-1010 effective in treatment of major depressive disorder: Study

Cipher Phase 3 dermatology study uses MedAvante Centralized Ratings

Integrating smoking cessation treatment with mental health care improves abstinence rates in PTSD veterans

Sleep deprivation eliminates fear-associated memories

Omega-3 fatty acids have antidepressant properties: Study

Loss of healthy bacteria may contribute to increasing rates of depression, say researchers

Research to improve prognosis for patients with dementia and Alzheimer's disease

FDA advisory committee's approval of Contrave for obesity encourages OAC, TOS, ASMBS

Jackson Health System selects MedAssets as its strategic partner

Alexza Pharmaceuticals to meet with FDA to discuss CRL regarding its NDA for AZ-004

Psychotic depression: the reason for treatment failure with antidepressants

Mental Health Research Network receives grant to create data resource for mental health researchers

Clinicians should specify subtypes of depression and combine antidepressants and psychotherapy

Expansion of newborn screening throws some families on a journey of great uncertainty

Major depression reduces success rate of quitting smoking

People suffering psychotic disorders 12 times more likely to commit suicide

Drug prescribed for Parkinson's disease may also treat restless leg syndrome: MCG researchers

Researchers develop new drugs to prevent post-traumatic stress syndrome

State roundup: Wash. state to pay most of state worker premiums; Budget cuts and mental health in N.Y.; Idaho fraud

Frisky old men - still keen and active: Sex study

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Mental Health News and Research

Latest Mental Health News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in